相关实验视频
Updated: Jun 28, 2025

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
10.9K
在市场和临床阶段的小干扰RNA交付的近期进展
Fan Guo1,2, Yan Li2,3, Wenjun Yu2,3
1School of Pharmacy, Binzhou Medical University, Shandong 264003, China.
Molecular pharmaceutics
|April 17, 2024
概括
五种小干扰RNA (siRNA) 药物已被批准用于肝脏疾病. 多种交付平台正在向各种组织推进siRNA疗法,许多药物正在临床试验中.
科学领域:
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 小干扰RNAs (siRNAs) 是一个有前途的治疗方式.
- 五种基于siRNA的药物已获得FDA和EC的批准,主要针对肝脏疾病.
- 目前的进展重点是扩大siRNA输送到肝脏之外.
研究的目的:
- 总结现有和新兴的siRNA传递技术.
- 审查siRNA疗法的最新临床应用.
- 为提供肝脏和肝外siRNA输送策略的概述.
主要方法:
- 对siRNA传递平台的文献综述.
- 对siRNA药物的临床试验数据的分析.
- 关于组织特异性siRNA向信息的综合.
主要成果:
- 已批准的siRNA药物在与肝脏相关的疾病中显示出有效性.
- 目前正在开发各种传递系统,以准大脑,肺,肌肉和其他组织.
- 许多siRNA候选药物正在进行临床试验.
结论:
- siRNA技术在临床应用中取得了重要的里程碑.
- 目前正在进行的研究正在扩大siRNAs的治疗潜力,将其应用于更广泛的疾病和组织.
- 先进的输送策略对于肝外siRNA疗法的成功至关重要.
相关概念视频
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Small interfering RNAs (siRNA)
3.5K
3.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K

